Jennifer Glennon

Jennifer Glennon serves as SVP of Global Research & Development and Medical & Product & Portfolio Strategy Finance at Ipsen, where responsibilities include overseeing a 400M€ annual budget and providing strategic guidance for product development and discovery teams. Prior to Ipsen, Jennifer held the position of Vice President of Finance and Operations at Evelo Biosciences, where significant company growth was achieved through building financial and operational frameworks. Jennifer has a track record of advising start-ups, notably at Blackfynn, and has held leadership roles in R&D Finance at both LEO Pharma and Maxygen. Jennifer's academic credentials include degrees from San Francisco State University and executive education from prestigious institutions such as London Business School and INSEAD.